IRIS
CELESIA, BENEDETTO MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.287
AS - Asia 3.073
EU - Europa 2.910
SA - Sud America 516
AF - Africa 411
Continente sconosciuto - Info sul continente non disponibili 226
OC - Oceania 7
Totale 12.430
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.077
SG - Singapore 1.468
RU - Federazione Russa 1.171
CN - Cina 734
IT - Italia 589
BR - Brasile 414
VN - Vietnam 305
IE - Irlanda 263
CI - Costa d'Avorio 192
DE - Germania 150
FR - Francia 147
KR - Corea 143
UA - Ucraina 140
CA - Canada 127
BD - Bangladesh 118
IN - India 117
NG - Nigeria 111
FI - Finlandia 94
SE - Svezia 92
GB - Regno Unito 75
SN - Senegal 43
HK - Hong Kong 39
NL - Olanda 39
PL - Polonia 39
MX - Messico 37
AR - Argentina 32
ES - Italia 25
ZA - Sudafrica 23
CO - Colombia 20
ID - Indonesia 19
IQ - Iraq 19
PK - Pakistan 17
JP - Giappone 15
BE - Belgio 14
EC - Ecuador 14
JM - Giamaica 14
AT - Austria 12
VE - Venezuela 12
TR - Turchia 11
GR - Grecia 10
CH - Svizzera 9
CL - Cile 9
KE - Kenya 9
LB - Libano 9
BJ - Benin 8
PY - Paraguay 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
IR - Iran 7
TN - Tunisia 7
AU - Australia 6
CR - Costa Rica 5
JO - Giordania 5
LT - Lituania 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
DK - Danimarca 4
EG - Egitto 4
HN - Honduras 4
LV - Lettonia 4
NP - Nepal 4
BO - Bolivia 3
BS - Bahamas 3
DO - Repubblica Dominicana 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
MY - Malesia 3
OM - Oman 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
DZ - Algeria 2
ET - Etiopia 2
KG - Kirghizistan 2
LC - Santa Lucia 2
MD - Moldavia 2
PH - Filippine 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BZ - Belize 1
CG - Congo 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
KZ - Kazakistan 1
LK - Sri Lanka 1
ME - Montenegro 1
MN - Mongolia 1
MT - Malta 1
MW - Malawi 1
NR - Nauru 1
Totale 12.194
Salva come PNG Salva come JPEG
Città #
Dallas 914
Singapore 884
Santa Clara 657
Moscow 523
San Jose 383
Chandler 379
Ashburn 304
Dublin 261
Los Angeles 207
Abidjan 192
Beijing 178
Chicago 169
Jacksonville 152
Seoul 143
Hefei 138
New York 125
Lauterbourg 124
Boardman 119
Catania 107
Ho Chi Minh City 97
Munich 89
Abuja 84
Buffalo 68
Cambridge 64
Hanoi 64
Lawrence 64
Council Bluffs 61
Civitanova Marche 57
São Paulo 56
Andover 55
Toronto 54
Helsinki 50
Kochi 48
Dakar 42
Rome 40
Hong Kong 36
Warsaw 36
Des Moines 35
Montreal 35
Nanjing 34
Orem 33
Houston 32
Lappeenranta 30
Brooklyn 29
Denver 28
Nanchang 25
Milan 24
Atlanta 23
Phoenix 22
Wilmington 22
Boston 20
London 20
The Dalles 20
Chennai 19
Lagos 19
Amsterdam 18
Columbus 18
Mexico City 17
Stockholm 17
Palermo 16
Philadelphia 16
Da Nang 15
Johannesburg 15
Poplar 15
San Mateo 15
Modica 14
Parma 14
Rio de Janeiro 14
Tokyo 14
Brussels 13
Rende 13
Changsha 12
Grafing 12
Mumbai 12
Shenyang 12
Bremen 11
Dong Ket 11
Jiaxing 11
Milazzo 11
San Francisco 11
Tremestieri Etneo 11
Hebei 10
Miami 10
Ottawa 10
Seattle 10
Charlotte 9
Madrid 9
Nairobi 9
New Delhi 9
Saint Petersburg 9
Cotonou 8
Manchester 8
Port Harcourt 8
Shanghai 8
Tashkent 8
Tianjin 8
Turku 8
Bari 7
Biên Hòa 7
Brasília 7
Totale 8.014
Salva come PNG Salva come JPEG
Nome #
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 337
A measles outbreak in Catania, Sicily: the importance of high vaccination coverage and early notification of cases for health and economic reasons 168
Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 163
[In Process Citation] 162
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 158
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study 157
Long-Term Survivors in a Cohort of People Living with HIV Diagnosed between 1985 and 1994: Predictive Factors Associated with More than 25 Years of Survival 146
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report 145
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis 137
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 135
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 135
Could we consider the intima-media thickness (c-IMT)> 1 mm as a risk factor for cardiovascular diseases in HIV plus subjects chronically treated with antiretrovirals? 126
Severe Neutropenia after Sarilumab Administration in Two COVID-19 Patients: Case Reports and Literature Review 125
Baseline CD4/CD8 T-cell Ratio Predicts Prompt Immune Restoration upon cART Initiation 122
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 120
HIV Infection Diagnosis in a Late Presenter Patient during a Severe Imported Falciparum Malaria: A Challenging 120
Anxiety disorders and adherence to HAART 118
Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature 118
Analysis of impediments to the maintenance in care of people with HIV in Italy 118
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 118
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 118
Long-term survivors in a cohort of HIV+ patients diagnosed between 1985 and 1992: predictive factors associated with more than 25 years of survival 118
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 117
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 116
Influence of hepatitis G virus coinfection on the clinical course of chronic hepatitis C 115
Hepatic echinococcosis: clinical and therapeutic aspects 112
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96-week retrospective study 111
HCV and HBV infection among multitransfused thalassemics from eastern Sicily 111
Entecavir resistance in a patient with treatment‑naïve HBV: A case report 110
Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review 110
Preliminary investigation on intrafamilial spread of hepatitis C virus (HCV) 109
Factors predicting tuberculosis reactivation in HIV-infected patients [PARAMETRI PREDITTIVI DI RIATTIVAZIONE TUBERCOLARE IN SOGGETTI CON INFEZIONE DA HIV] 109
High-flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID-19: A report of three cases and a literature review 108
Kidney disease in HIV-infected patients 106
Successful extracorporeal membrane oxygenation treatment in an acquired immune deficiency syndrome (AIDS) patient with acute respiratory distress syndrome (ARDS) complicating pneumocystis jirovecii pneumonia: A challenging case 106
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 104
Predictive criteria of sustained virological response (more than 60 months) to Nevirapine-based antiretroviral treatment 104
Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review 102
Trimethoprim-sulfamthoxazole associated severe hypoglicemia: a sulfnylurea like effect 102
Efficacy and safety of Atazanavir/Ritonavir therapy in a cohort of treatment-experienced patients 101
Editorial-Coronavirus disease 2019 and people living with HIV: Clinical considerations 101
Possible role of low dose dexamethasone administration in listeria monocytogenes meningoencephalitis: A case series 100
The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy 99
Ruolo del rapporto eterosessuale nella trasmissione dell’infezione HIV in un gruppo di tossicodipendenti della Sicilia Orientale. Necessità di modificare le strategie di prevenzione? 99
Pain crisis management in a patient with sickle cell disease during SARS‑CoV‑2 infection: A case report and literature review 99
Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience 99
Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature 98
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 98
Laryngeal leishmaniasis in a HIV‑positive patient: A case report and review of the literature 97
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 97
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 96
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 96
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 95
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 94
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 91
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders 91
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study 90
Sifilide ed HIV.Presentazione di tre casi clinici 90
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 89
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 89
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment 89
Serum tumor necrosis factor in acute and fulminant hepatitis B 88
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 88
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 88
Test for CCR5 tropism and treatment with maraviroc in Sicily: an observational retrospective multicentre study 88
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 86
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 86
Microbial translocation in chronic liver diseases 82
Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily 81
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 81
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals 80
Ageing with HIV: a multidisciplinary review 80
Localizzazione osteoarticolare multipla in corso di sepsi da Staphylococcus aureus meticillino-resistente: Considerazioni clinico- terapeutiche [Multiple osteo-articular involvement due to methicillin-resistant Staphylococcus aureus septicaemia: clinical and therapeutic evaluation] 80
Long-acting drugs: people's expectations and physicians' preparedness. Are we readying to manage it? An Italian survey 79
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 79
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 79
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV 77
High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: A cross-sectional study 77
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 76
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial 76
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 76
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 75
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 75
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 73
Sexual dysfunction in HIV plus subjects in eastern Sicily 73
HCV and HIV infection among intravenous drug abusers in eastern Sicily 73
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort 73
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 73
Factors associated with weight gain in people treated with dolutegravir 73
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 72
Diagnosis, Treatment, and Prevention of HIV Infection among Detainees: A Review of the Literature 71
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 71
Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report 70
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 69
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 68
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment 67
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 66
Weight gain: A possible side effect of all antiretrovirals 66
PrEP in Italy: The time may be ripe but who’s paying the bill? A nationwide survey on physicians’ attitudes towards using antiretrovirals to prevent HIV infection 66
Archi-Prevaleat project. A national register of color-doppler ultrasonography of the epi-aortic vessels in patients living with HIV 66
Totale 10.081
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.825
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022430 0 61 12 5 65 8 72 27 46 11 20 103
2022/20231.035 71 67 14 101 106 171 5 177 245 5 40 33
2023/2024496 28 63 21 32 22 135 5 35 4 22 79 50
2024/20252.656 25 287 110 104 567 334 92 86 236 276 293 246
2025/20266.723 382 380 1.081 530 1.065 1.344 641 159 276 403 229 233
2026/2027371 275 96 0 0 0 0 0 0 0 0 0 0
Totale 12.430